Skip to main navigation Skip to search Skip to main content

Metformin for lithium-induced weight gain: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

Lithium is the first line treatment for maintenance treatment of bipolar disorder. Among the long term adverse effects, weight gain is likely to affect a subset of patients. There is no specific guideline for the treatment of lithium-induced weight gain. We report a young male with bipolar disorder who had significant weight gain with lithium (25 kg), which responded to metformin treatment at 500 mg twice daily. The proposed mechanism of weight lowering effect of metformin includes changes in hypothalamic physiology, including leptin and insulin sensitivity, as well as circadian rhythm changes affecting food intake, regulation of fat oxidation and storage in liver, skeletal muscle, and adipose tissue.

Original languageEnglish
Pages (from-to)101-103
Number of pages3
JournalClinical Psychopharmacology and Neuroscience
Volume14
Issue number1
DOIs
Publication statusPublished - 01-01-2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Metformin for lithium-induced weight gain: A case report'. Together they form a unique fingerprint.

Cite this